Atlas Trials

Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AML

Clinical trial NCT05053425 · UNKNOWN

Trial details

NCT number
NCT05053425
Sponsor
LanZhou University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2021-10-20
Primary completion
2023-01-18
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.